Regulatory PathRegulatory requirements compared

Active substances

Calcium chloride + Potassium chloride + Sodium chloride

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
RINGER SOLUTION I.V INFUSION8.6,0.30,0.33 g/ml,g/ml,g/mlIntravenous infusion · Intravenous use1 BagSAR 4.95Generic · PrescriptionGULF INJECTValid
RINGERS INJECATION 500 ML SOLUTION0.85,0.03,0.33 %,%,%Solution · Intravenous use1 BagSAR 4.75Generic · PrescriptionKUWAIT SAUDI PHARMACEUTICAL INDUSTRIESValid
RINGERS SOLUTION8.6,0.30,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BagSAR 11.10Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
RINGERS SOLUTION8.6,0.30,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BottleSAR 3.40Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
RINGERS SOLUTION8.6,0.30,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BottleSAR 9.25Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
RINGERS SOLUTION8.6,0.3,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BottleSAR 8.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
RINGERS SOLUTION8.6,0.30,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BottleSAR 9.00Generic · PrescriptionPharmaceutical Solution Industries (PSI)Valid
RINGERS SOLUTION8.6,0.30,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BottleSAR 10.75Generic · PrescriptionPharmaceutical Solution Industries (PSI)Withdrawn by MAH · Not Marketed
RINGERS SOLUTION FOR I.V. INFUSION IN VIAFLEX8.6,0.3,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BagSAR 11.10Generic · PrescriptionBaxter Company LimitedWithdrawn by MAH · Not Marketed
RINGERS SOLUTION FOR I.V. INFUSION IN VIAFLEX8.6,0.3,0.33 g/ml,g/ml,g/mlSolution · Intravenous use1 BagSAR 5.45Generic · PrescriptionBaxter Company LimitedWithdrawn by MAH · Not Marketed
Indications — CHI Daman Drug Formulary

ACUTE KIDNEY INJURY (AKI); ACUTE PANCREATITIS; ANESTHESIA-SUPPORTIVE AGENTS/ FLUID RESUSCITATION (UNCONTROLLED BLEEDING); CENTRAL DIABETES INSIPIDUS; FLUIDS AND VOLUME EXPANDERS-RESUSCITATION

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLinjectable · injectionBAXTER HLTHCAREPrescription22 Mar 1971
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLsolution · irrigationOTSUKA ICU MEDCLPrescription14 May 1976
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLsolution · irrigationB BRAUNPrescription6 Aug 1979
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLinjectable · injectionOTSUKA ICU MEDCLPrescription16 May 1980
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLsolution · irrigationBAXTER HLTHCAREPrescription19 Feb 1982
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLinjectable · injectionB BRAUNPrescription17 Apr 1992
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLinjectable · injectionB BRAUNDiscontinued9 Nov 1982
RINGER'S IN PLASTIC CONTAINER33MG/100ML;30MG/100ML;860MG/100MLsolution · irrigationABBOTTDiscontinued

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.